Journal of Pharmacovigilance

Astudy of the Adverse Drug Reactions (ADR) reported/documented at ADR monitoring centre under pharmacovigilance program of India at Silchar Medical College & Hospital

3^rd International Conference and Exhibition on Pharmacovigilance & Clinical Trials

October 27-29, 2014 Hyderabad International Convention Centre, India

Navajit Sahu, Babul Dewan and Pinaki Chakravarty

Accepted Abstracts: J Pharmacovigilance

Abstract:

Introduction: Pharmacovigilance plays an important role in rational use of drugs by providing information about Adverse Drug Reactions (ADRs). ADRs are often preventable, cause of illness, disability and even death. This study was to observe the pattern of ADRs reported to ADRs Monitoring Centre of Silchar Medical College & Hospital, Assam. Method: This is a prospective observational study carried out at ADR Monitoring Centre (AMC) under Pharmacovigilance Programme of India (PvPI) at Silchar Medical College& Hospital, Silchar, Assam. All the ADRs reported to AMC, from the different clinical departments of Silchar Medical College & Hospital were collected and analysed. Results: The maximum numbers of ADRs were due to antibacterials, followed by highly active antiretroviral drugs (HAART). Among the HAART, nevirapine accounted for the maximum numbers of ADRs. Maculopapular rash is the commonest ADR reported to our centre. Conclusions: Antibacterials were the commonest group of drugs causing ADRs and the most commonly observed ADR wasmaculopapular rash.

Biography :

Navajit Sahu has completed his MD in Pharmacology from Assam Medical College (Dibrugarh University) in 2008. He is Demonstrator in the Department of Pharmacology, Silchar Medical College, Silchar. He has 4 publications in his name. Previously he worked as a Principal Investigator of Ashco Niulab Industries Limited, Mumbai and as Medical advisor of Zuventus Healthcare Limited, Mumbai.